share_log

Needham:重申Rocket Pharmaceuticals(RCKT.US)评级,由买入调整至买入评级, 目标价53.00美元。

Needham: Reiterated Rocket Pharmaceuticals (RCKT.US) rating, adjusted from buy to buy rating, target price $53.00.

Zhitong Finance ·  Apr 10 18:11
Needham: Reiterated Rocket Pharmaceuticals (RCKT.US) rating, adjusted from buy to buy rating, target price $53.00.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment